Raymond S Hurst

Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.

Stephen M Stahl, S. Stahl, R. Hurst, 2007, Trends in pharmacological sciences.

Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.

Brandon J. Margolis, Mihaly Hajos, Thomas J. Raub, 2006, Bioorganic & medicinal chemistry.